These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Induction of prostaglandin endoperoxide synthase-2 by serine-threonine phosphatase inhibition.
    Author: Mahboubi K, Young W, Ferreri NR.
    Journal: J Pharmacol Exp Ther; 1997 Jul; 282(1):452-8. PubMed ID: 9223587.
    Abstract:
    Regulation of prostaglandin endoperoxide synthase-2 (PGHS-2) mRNA levels by serine-threonine phosphatases was examined in murine fibrosarcoma methylcholanthrene-101 cells. Okadaic acid (OA), a serine-threonine phosphatase inhibitor, induced PGE2 production and a significant increase in PGHS-2 immunoreactive protein. A specific PGHS-2 inhibitor, N-(2-cyclohexyloxy-4-nitrophenyl) methanesulphonamide, completely abolished the OA-mediated increase in PGE2 production, which suggests that the PGE2 formed in response to OA was derived from PGHS-2. OA-mediated PGHS-2 mRNA accumulation was observed at 1 hr, remained elevated for 24 hr and was blocked by actinomycin D, which indicates that OA increases PGHS-2 gene transcription. A significant post-transcriptional mechanism also contributed to the increased PGHS-2 mRNA accumulation, because the mRNA half-life was approximately 4 to 5 h in OA-stimulated cells. Tumor necrosis factor-alpha, but not OA, activated transcription factor nuclear factor-kappaB in methylcholanthrene-101 cells, as demonstrated by translocation of the nuclear factor-kappaB complex to the nucleus and disappearance of the cytoplasmic inhibitory protein, IkappaB-alpha. We conclude that inhibition of serine-threonine phosphatases contributes to the up-regulation of PGHS-2 expression in an NF-kappaB-independent manner.
    [Abstract] [Full Text] [Related] [New Search]